These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 3087427
41. Glyconamides as inhibitors of human beta-glucosidases and beta-galactosidases. Chiao YB, Moffitt K, Smallwood Y, Glew RH, Naoi M, Lee YC. Arch Biochem Biophys; 1979 Jan; 192(1):1-9. PubMed ID: 107857 [No Abstract] [Full Text] [Related]
42. Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease. Aerts JM, Donker-Koopman WE, Koot M, Barranger JA, Tager JM, Schram AW. Clin Chim Acta; 1986 Jul 30; 158(2):155-63. PubMed ID: 2943536 [Abstract] [Full Text] [Related]
43. Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels. Xu YH, Reboulet R, Quinn B, Huelsken J, Witte D, Grabowski GA. Mol Genet Metab; 2008 Jun 30; 94(2):190-203. PubMed ID: 18346921 [Abstract] [Full Text] [Related]
45. Characterization of the phospholipid requirement of a rat liver beta-glucosidase. Basu A, Glew RH. Biochem J; 1984 Dec 01; 224(2):515-24. PubMed ID: 6517862 [Abstract] [Full Text] [Related]
46. Secondary sphingolipid accumulation in a macrophage model of Gaucher disease. Hein LK, Meikle PJ, Hopwood JJ, Fuller M. Mol Genet Metab; 2007 Dec 01; 92(4):336-45. PubMed ID: 17881272 [Abstract] [Full Text] [Related]
47. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. Bondar C, Ormazabal M, Crivaro A, Ferreyra-Compagnucci M, Delpino MV, Rozenfeld PA, Mucci JM. Int J Mol Sci; 2017 Jan 13; 18(1):. PubMed ID: 28098793 [Abstract] [Full Text] [Related]
48. Expression of cytosolic beta-glucosidase in guinea pig liver cells. Hays WS, Wheeler DE, Eghtesad B, Glew RH, Johnston DE. Hepatology; 1998 Jul 13; 28(1):156-63. PubMed ID: 9657108 [Abstract] [Full Text] [Related]
49. Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site. Dinur T, Osiecki KM, Legler G, Gatt S, Desnick RJ, Grabowski GA. Proc Natl Acad Sci U S A; 1986 Mar 13; 83(6):1660-4. PubMed ID: 3456607 [Abstract] [Full Text] [Related]
51. Lysosomal beta-glucosidase of rat liver. Fabbro D, Desnick RJ, Gatt S. Enzyme; 1984 Mar 13; 31(2):122-7. PubMed ID: 6426948 [Abstract] [Full Text] [Related]
52. Destruction and resynthesis of mouse beta-glucosidases. Hara A, Radin NS. Biochim Biophys Acta; 1979 Feb 01; 582(3):412-22. PubMed ID: 33720 [Abstract] [Full Text] [Related]
53. 2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase. Glew RH, Gopalan V, Hubbell CA, Devraj RV, Lawson RA, Diven WF, Mannock DA. Biochem J; 1991 Mar 01; 274 ( Pt 2)(Pt 2):557-63. PubMed ID: 1900989 [Abstract] [Full Text] [Related]
55. Synthesis of novel mono and bis-indole conduritol derivatives and their α/β-glycosidase inhibitory effects. Çavdar H, Talaz O, Ekinci D. Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7499-503. PubMed ID: 23137433 [Abstract] [Full Text] [Related]
56. In vitro detergent activation of lysosomal acid beta-glucosidase in the spleen of normal and type 1 Gaucher patients is not accompanied by change in aggregation state. Maret A, Potier M, Salvayre R, Troly M, Beauregard G, Douste-Blazy L. Biochim Biophys Acta; 1989 Jul 06; 996(3):254-6. PubMed ID: 2502183 [Abstract] [Full Text] [Related]
57. Liposomes in Gaucher type I disease: use in enzyme therapy and the creation of an animal model. Gregoriadis G, Weereratne H, Blair H, Bull GM. Prog Clin Biol Res; 1982 Jul 06; 95():681-701. PubMed ID: 6812092 [No Abstract] [Full Text] [Related]
58. Studies on the turnover of glucocerebrosidase in cultured rat peritoneal macrophages and normal human fibroblasts. Das PK, Murray GJ, Barranger JA. Eur J Biochem; 1986 Jan 15; 154(2):445-50. PubMed ID: 3943537 [Abstract] [Full Text] [Related]
59. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. Grabowski GA, Goldblatt J, Dinur T, Kruse J, Svennerholm L, Gatt S, Desnick RJ. Am J Med Genet; 1985 Jul 15; 21(3):529-49. PubMed ID: 3927728 [Abstract] [Full Text] [Related]
60. The mechanism of action of beta-glucosidase from Botryodiplodia theobromae Pat. Umezurike GM. Biochem J; 1987 Jan 15; 241(2):455-62. PubMed ID: 3109376 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]